Pharma

Global Transient Ischemic Attack Market Opportunities and Forecast 2020-2027

  • DLR2192
  • 12 February, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Transient Ischemic Attack Market, By Diagnosis (Computed Tomography (CT) Scan, Carotid Duplex Scanning, Magnetic Resonance Imaging, Echocardiography) By Treatment (Drugs, Surgery) By End User (Hospitals & Clinics, Diagnostic Centers, Research Laboratories), and opportunities and forecast 2020-2027

Transient Ischemic Attack Market Overview

The global Transient Ischemic Attack market is projected to rise at a significant rate in the forthcoming years.  A short blockage in the blood supply to a region of the brain causes a transient ischemic attack (TIA), sometimes known as a "mini-stroke." A lack of oxygen to the brain is caused by an interruption in blood supply, which causes sudden symptoms similar to a stroke, such as visual and speech disturbances, as well as numbness or weakness in the arms, face, and legs.

The global transient ischemic attack market is predicted to rise rapidly throughout the forecast period, owing to rising investments in biotechnology and pharmaceutical research, as well as growing demand for better treatment options. Furthermore, the global transient ischemic attack market is being driven by the rising frequency of neurological illnesses and the growing global elderly population.

On the negative side, over the projection period, a shortage of experienced physicians and surgeons, as well as rising treatment and hospitalization costs, are expected to hinder market expansion.

Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Diagnosis, Treatment, End User, and Region.
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered Koninklijke Philips N.V., Stryker Corporation, Johnson & Johnson Services Inc., Boston Scientific Corporation, Sanofi SA, Bayer AG, Pfizer Inc., Siemens AG, GE Healthcare, Penumbra, Inc., F. Hoffmann-La Roche AG, Medtronic PLC, Abbott Laboratories, Merck & Co., Inc., Boehringer Ingelheim GmbH, LivaNova PLC, Cyberonics, Inc, NeuroMetrix, Inc.


Covid-19 Impact on Transient Ischemic Attack Market
 
In addition, the current Transient Ischemic Attack Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Transient Ischemic Attack Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long-term as well as short-term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Transient Ischemic Attack Market Segment Overview



According to Diagnosis, Magnetic Resonance Imaging (MRI) segment holds the largest share in the global Transient Ischemic Attack market. This is primarily attributed to better imaging quality and better suitability of the magnetic resonance imaging (MRI) technique. Furthermore, by Treatment, Drugs is one of the largest segments in the global Transient Ischemic Attack market. Drugs are the first line of treatment for curing transient ischemic attacks. Several companies are investing highly in the research and development activities for the new drug development for the treatment of transient ischemic attacks.
 
Transient Ischemic Attack Market, By Diagnosis
·       Computed Tomography (CT) Scan
·       Carotid Duplex Scanning
·       Magnetic Resonance Imaging
·       Echocardiography
 
Transient Ischemic Attack Market, By Treatment
·       Drugs
·       Surgery

Transient Ischemic Attack Market, By End User
·       Hospitals & Clinics
·       Diagnostic Centers
·       Research Laboratories
 
Transient Ischemic Attack Regional Overview

Geographically, North America emerged as the dominant region in the global transient ischemic attack market due to factors such as the rising prevalence of neurological disorders, high per capita healthcare expenditure, increasing government support for research and development activities, and the presence of major pharmaceutical companies. Moreover, the market in the Asia Pacific is expected to rise at a considerable rate in the coming period. Major factors such as improvement in healthcare facilities and an increase in awareness relating to personal health are anticipated to boost the growth of the transient ischemic attack market in this region.

Transient Ischemic Attack Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Transient Ischemic Attack Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Transient Ischemic Attack are highlighted below.

·       In August 2021, Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's Amplatzer™ Amulet™ Left Atrial Appendage Occluder to treat people with atrial fibrillation (AFib) who are at risk of ischemic stroke. The device offers immediate closure of the left atrial appendage (LAA) – an area where blood clots can form in people suffering from AFib – reducing their risk of stroke and immediately eliminating the need for blood-thinning medication.
 
Transient Ischemic Attack Market, Key Players

·       Koninklijke Philips N.V.
·       Stryker Corporation
·       Johnson & Johnson Services Inc.
·       Boston Scientific Corporation
·       Sanofi SA
·       Bayer AG
·       Pfizer Inc.
·       Siemens AG
·       GE Healthcare
·       Penumbra, Inc.
·       F. Hoffmann-La Roche AG
·       Medtronic PLC
·       Abbott Laboratories
·       Merck & Co., Inc.
·       Boehringer Ingelheim GmbH
·       LivaNova PLC
·       Cyberonics, Inc
·       NeuroMetrix, Inc.

Frequently Asked Questions (FAQ) :

Q1. What are the driving factors for the global Transient Ischemic Attack market?

A. The global transient ischemic attack market is predicted to rise rapidly throughout the forecast period, owing to rising investments in biotechnology and pharmaceutical research, as well as growing demand for better treatment options.

Q2. What are the restraining factors for the global Transient Ischemic Attack market?

A. Over the projection period, a shortage of experienced physicians and surgeons, as well as rising treatment and hospitalization costs, are expected to hinder market expansion.

Q3. Which segment is projected to hold the largest share in the global Transient Ischemic Attack Market?

A. Magnetic Resonance Imaging (MRI) segment is projected to hold the largest share in the global Transient Ischemic Attack Market.

Q4. Which region holds the largest share in the global Transient Ischemic Attack market?

A. North America held the largest share in the global Transient Ischemic Attack market

Q5. Which are the prominent players in the global Transient Ischemic Attack Market?

A. Koninklijke Philips N.V., Stryker Corporation, Johnson & Johnson Services Inc., Boston Scientific Corporation, Sanofi SA, Bayer AG, Pfizer Inc., Siemens AG, GE Healthcare, Penumbra, Inc., F. Hoffmann-La Roche AG, Medtronic PLC, Abbott Laboratories, Merck & Co., Inc., Boehringer Ingelheim GmbH, LivaNova PLC, Cyberonics, Inc, NeuroMetrix, Inc. are some key players in the global Transient Ischemic Attack Market.
Transient Ischemic Attack Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Transient Ischemic Attack Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Diagnosis
        • 5.2.1. Computed Tomography (CT) Scan
        • 5.2.2. Carotid Duplex Scanning
        • 5.2.3. Magnetic Resonance Imaging
        • 5.2.4. Echocardiography
      • 5.3. Market Analysis, Insights and Forecast – By Treatment
        • 5.3.1. Drugs
        • 5.3.2. Surgery
      • 5.4. Market Analysis, Insights and Forecast – By End User
        • 5.4.1. Hospitals & Clinics
        • 5.4.2. Diagnostic Centers
        • 5.4.3. Research Laboratories
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Europe
        • 5.5.3. Asia Pacific
        • 5.5.4. Latin America, Middle East and Africa

      6. North America Transient Ischemic Attack Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Diagnosis
        • 6.2.1. Computed Tomography (CT) Scan
        • 6.2.2. Carotid Duplex Scanning
        • 6.2.3. Magnetic Resonance Imaging
        • 6.2.4. Echocardiography
      • 6.3. Market Analysis, Insights and Forecast – By Treatment
        • 6.3.1. Drugs
        • 6.3.2. Surgery
      • 6.4. Market Analysis, Insights and Forecast – By End User
        • 6.4.1. Hospitals & Clinics
        • 6.4.2. Diagnostic Centers
        • 6.4.3. Research Laboratories
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Europe Transient Ischemic Attack Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Diagnosis
        • 7.2.1. Computed Tomography (CT) Scan
        • 7.2.2. Carotid Duplex Scanning
        • 7.2.3. Magnetic Resonance Imaging
        • 7.2.4. Echocardiography
      • 7.3. Market Analysis, Insights and Forecast – By Treatment
        • 7.3.1. Drugs
        • 7.3.2. Surgery
      • 7.4. Market Analysis, Insights and Forecast – By End User
        • 7.4.1. Hospitals & Clinics
        • 7.4.2. Diagnostic Centers
        • 7.4.3. Research Laboratories
      • 7.5. Market Analysis, Insights and Forecast – By Country
        • 7.5.1. UK
        • 7.5.2. Germany
        • 7.5.3. France
        • 7.5.4. Italy
        • 7.5.5. Spain
        • 7.5.6. Russia
        • 7.5.7. Rest of Europe

      8. Asia Pacific Transient Ischemic Attack Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Diagnosis
        • 8.2.1. Computed Tomography (CT) Scan
        • 8.2.2. Carotid Duplex Scanning
        • 8.2.3. Magnetic Resonance Imaging
        • 8.2.4. Echocardiography
      • 8.3. Market Analysis, Insights and Forecast – By Treatment
        • 8.3.1. Drugs
        • 8.3.2. Surgery
      • 8.4. Market Analysis, Insights and Forecast – By End User
        • 8.4.1. Hospitals & Clinics
        • 8.4.2. Diagnostic Centers
        • 8.4.3. Research Laboratories
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. China
        • 8.5.2. India
        • 8.5.3. Japan
        • 8.5.4. Australia
        • 8.5.5. South East Asia
        • 8.5.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Transient Ischemic Attack Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Diagnosis
        • 9.2.1. Computed Tomography (CT) Scan
        • 9.2.2. Carotid Duplex Scanning
        • 9.2.3. Magnetic Resonance Imaging
        • 9.2.4. Echocardiography
      • 9.3. Market Analysis, Insights and Forecast – By Treatment
        • 9.3.1. Drugs
        • 9.3.2. Surgery
      • 9.4. Market Analysis, Insights and Forecast – By End User
        • 9.4.1. Hospitals & Clinics
        • 9.4.2. Diagnostic Centers
        • 9.4.3. Research Laboratories
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. Brazil
        • 9.5.2. Saudi Arabia
        • 9.5.3. UAE
        • 9.5.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Koninklijke Philips N.V.
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Stryker Corporation
      • 10.6. Johnson & Johnson Services Inc.
      • 10.7. Boston Scientific Corporation
      • 10.8. Sanofi SA
      • 10.9. Bayer AG
      • 10.10. Pfizer Inc.
      • 10.11. Siemens AG
      • 10.12. GE Healthcare
      • 10.13. Penumbra, Inc.
      • 10.14. F. Hoffmann-La Roche AG
      • 10.15. Medtronic PLC
      • 10.16. Abbott Laboratories
      • 10.17. Merck & Co., Inc.
      • 10.18. Boehringer Ingelheim GmbH
      • 10.19. LivaNova PLC
      • 10.20. Cyberonics, Inc
      List of Figures

      Figure 1: Global Transient Ischemic Attack Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Transient Ischemic Attack Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Transient Ischemic Attack Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Transient Ischemic Attack Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Transient Ischemic Attack Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Transient Ischemic Attack Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Transient Ischemic Attack Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Transient Ischemic Attack Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Transient Ischemic Attack Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Transient Ischemic Attack Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Transient Ischemic Attack Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Transient Ischemic Attack Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Transient Ischemic Attack Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Transient Ischemic Attack Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934